The drug "Thrombo ACC" is an antiplatelet agent . The medication helps to reduce blood coagulation. One tablet of Trombo ACC 100 contains one hundred milligrams of acetylsalicylic acid.
The mechanism of drug action is based on the ability to reduce platelet aggregation by suppressing the synthesis of thromboxane A2 (a mediator of degranulation and aggregation) in them. The drug "Thrombo ACC", analogues of the drug (Aspicor, Aspirin, Acekardol and others) contribute to a decrease in serum concentrations of the specified mediator and its products. Low levels persist for an extended period.
The drug "Thrombo ACC" is resistant to gastric juice. This reduces the incidence of adverse reactions from the gastrointestinal tract to a significant extent.
The medicine "Thrombo ACC". Instruction Indications.
The drug is prescribed for secondary and primary prevention of myocardial infarction, to reduce its development among patients with coronary artery disease. The tool "Thrombo ACC" instruction recommends use to prevent circulatory disorders in the brain according to the ischemic type, the formation of embolism and thrombosis. The drug is used for these purposes, including in patients who are predisposed to the formation of blood clots (after coronary artery bypass grafting, vascular and heart surgery).
The medicine "Thrombo ACC". Instructions for use.
The tablets are taken orally without chewing. It is necessary to drink plenty of water. It is recommended to take 50 or 100 mg once a day.
When using the drug "Thrombo ACC", the instruction indicates a low probability of an overdose, due to the low content of acetylsalicylic acid in the medication. Presumably, the condition may be accompanied by vomiting, general malaise, tinnitus, nausea. As therapy, artificial vomiting is used. Activated carbon is prescribed inside, and the acid-base balance is adjusted.
The drug “Thrombo ACC” is contraindicated in case of hypersensitivity, exacerbations of erosive and ulcerative lesions in the gastrointestinal tract, hemophilia, coagulation disorders, nephrolithiasis, hypothrombinemia, aspirin triad, increased bleeding. Do not prescribe the drug for lactation, a lack of glucose-6-phosphate dehydrogenase, for children under eighteen years of age.
With caution, the drug should be prescribed with a history of individual intolerance to NSAIDs, the remission stage of inflammatory and erosive-ulcerative pathologies in the gastrointestinal tract, and disorders in the activity of the liver and kidneys.
The drug is not recommended during pregnancy.
As practice shows, the tool "Thrombo ACC" is well tolerated by patients. Adverse reactions were rare. Among them should be called vomiting, diarrhea, nausea, bleeding in the gastrointestinal tract of a hidden nature and, as a consequence, iron deficiency anemia. In addition, bronchospasm, thrombocytopenia, an increase in the period of the menstrual cycle, skin rash, exacerbation of bronchial asthma are possible.
Long-term use at high dosages causes impaired renal function, tinnitus, dizziness, bleeding, and gastrointestinal ulcers.
In clinical practice, no addiction to the drug has been reported.
The drug "Thrombo ACC" is able to enhance the properties of NSAIDs, oral anticoagulants and hypoglycemic agents.
The complex use of the drug with alcohol and glucocorticoids increases the likelihood of bleeding in the digestive tract.
The use of Trombo ACC reduces the effects of diuretics (furosemide, spironolactone), anti-gout uricosuric drugs. If necessary, the integrated use of the interval between doses - at least one to three hours.
The shelf life of the drug "Thrombo ACC" is three years. The medication should not be used after the specified period.